MedPath

DOSE-dependent response of polyphenols from GRAPE extract on polyphenols bioavailability

Not Applicable
Completed
Conditions
Concentration of polyphenols in urine and their kinetics in plasma
Not Applicable
Registration Number
ISRCTN06777936
Lead Sponsor
Ministry of Economy and Competitiveness ? INNPRONTA (Miguel Torres S.A) (Spain)
Brief Summary

1. 2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28964366 (added 22/01/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria

Healthy adults (females and males), aged 20-40 years

Exclusion Criteria

1. Previous history of cardiovascular disease (ischemic heart disease - angina or recent or old myocardial infarction, cerebral vascular accident, or peripheral vascular disease)
2. Homeostatic disorders
3. Any several chronic diseases
4. Hypertension or dyslipidemia
5. Grape intolerance or allergic
6. Smoking subjects
7. Alcoholism
8. Other toxic abuse

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Polyphenols will be identified through liquid chromatography coupled to Orbitrap mass spectrometry. Concentrations of polyphenols will be quantified by liquid chromatography coupled to tandem mass spectrometry (LC?MS/MS). Polyphenols will be quantified at 0 to 24 hours of each intervention.
Secondary Outcome Measures
NameTimeMethod
<br> Before (0 hours) and after each intervention (6 hours) the following measures were taken:<br> 1. Blood pressure<br> 2. Body weight<br> 3. Waist perimeter<br> 4. Glucose<br> 5. Lipid profile<br> 6. Biomarkers of oxidative stress and systematic inflammation<br> 7. Coagulation factor and vitamin levels<br>
© Copyright 2025. All Rights Reserved by MedPath